Non-invasive Cancer Detection System Uses Sensing Ocean Optics Expertise
Dec 20 2005 Read 2368 Times
Developed by the Bioscience Division of the U.S. Department of Energy, the technology has been licensed to, and further developed by, SpectraPath Technologies. It is hoped that the system will allow physicians to screen patients quickly, providing instant diagnoses, without requiring invasive and time-consuming biopsies for skin, cervical, brain, oesophageal and colorectal cancers.
At the heart of the system is a USB2000 palm sized spectrometer. It is used to analyse the elastic light scattering (ELS) spectrum produced by cellular nuclei. An LS-1 Tungsten Halogen Light Source and single optical fibre probe are used to illuminate the tissue surface. The probe then captures the resulting ELS spectrum. Larger nuclei in cancerous and pre-cancerous cells cause different ELS spectra from normal nuclei.
The CancerScanner? has so far been successfully tested in both animals and humans for a variety of cancer types. It is small, lightweight, and will be economically practical for hospitals, physician offices and patient services centres.
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles - Export experts talk Corona Virus - Automated cell counting shouldn’t cost the earth Laboratory Products - Spectrophotometer Linearity Validation - Analysi...
View all digital editions
Jun 11 2020 Brussels, Belgium
Jun 20 2020 San Diego, CA, USA
Jun 30 2020 Nuremberg, Germany
Jul 27 2020 Kintex, South Korea
Aug 13 2020 Shanghai, China